head activator peptide has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Druffel-Augustin, S; Dübel, S; Schaller, HC | 1 |
| Bodenmüller, H; Sachsenheimer, W; Schaller, HC; Schilling, E; Theilmann, L | 1 |
2 other study(ies) available for head activator peptide and Glioma
| Article | Year |
|---|---|
Head activator acts as an autocrine growth factor for NH15-CA2 cells in the G2/mitosis transition.
Topics: Animals; Binding Sites; Cell Division; Chromatography, High Pressure Liquid; DNA; Glioma; Growth Substances; Hybrid Cells; Immunohistochemistry; Interphase; Mice; Mitosis; Neuroblastoma; Neurons; Neuropeptides; Pyrrolidonecarboxylic Acid; Rats; Tumor Cells, Cultured | 1989 |
Elevated levels of head activator in human brain tumors and in serum of patients with brain and other neurally derived tumors.
Topics: Animals; Astrocytoma; Brain Neoplasms; Cell Line; Gastrointestinal Neoplasms; Glioma; Humans; Meningioma; Neuropeptides; Pituitary Neoplasms; Pyrrolidonecarboxylic Acid; Rats | 1988 |